1. |
中华医学会眼科学分会眼免疫学组, 中国医师协会眼科医师分会葡萄膜炎与免疫学组. 中国Fuchs葡萄膜炎综合征临床诊疗专家共识(2022年)[J]. 中华眼科杂志, 2022, 58(7): 500-505. DOI: 10.3760/cma.j.cn112142-20220124-00030.Ocular Immunology Group, Chinese Society of Ophthalmology, Chinese Medical Association; Uveitis and Immunology Group, Chinese Ophthalmologist Association, Chinese Medical Doctor Association. Chinese expert consensus on clinical diagnosis and management of fuchs uveitis syndrome (2022)[J]. Chin J Ophthalmol, 2022, 58(7): 500-505. DOI: 10.3760/cma.j.cn112142-20220124-00030.
|
2. |
Yang P, Zhang W, Chen Z, et al. Development of revised diagnostic criteria for Fuchs' uveitis syndrome in a Chinese population[J]. Br J Ophthalmol, 2022, 106(12): 1678-1683. DOI: 10.1136/bjophthalmol-2021-319343.
|
3. |
Liu H, Lai Y, Liu Y, et al. Clinical characteristics of viral-associated Fuchs uveitis syndrome and Posner-Schlossman syndrome in a Chinese population[J]. Graefe's Arch Clin Exp Ophthalmol, 2024, 262(10): 3305-3312. DOI: 10.1007/s00417-024-06502-0.
|
4. |
Brichová M, Lízrová JP, Heissigerová J, et al. Association of fuchs heterochromic iridocyclitis with multiple sclerosis[J]. Cesk Slov Oftalmol, 2024, 80(4): 188-192. DOI: 10.31348/2024/17.
|
5. |
Sun Y, Ji Y. A literature review on Fuchs uveitis syndrome: an update[J]. Surv Ophthalmol, 2020, 65(2): 133-143. DOI: 10.1016/j.survophthal.2019.10.003.
|
6. |
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for Fuchs uveitis syndrome[J]. Am J Ophthalmol, 2021, 228: 262-267. DOI: 10.1016/j.ajo.2021.03.052.
|
7. |
Kawali A, Sriram R, Srinivasan S, et al. Evolving Fuchs' uveitis-a diagnostic challenge[J]. Indian J Ophthalmol, 2024, 72(6): 885-889. DOI: 10.4103/IJO.IJO_1151_23.
|
8. |
Yoneda Y, Usui Y, Tanaka R, et al. Factors associated with low prevalence of Fuchs' uveitis syndrome in Japan[J/OL]. Front Med (Lausanne), 2022, 9: 999804[2022-09-30]. https://pubmed.ncbi.nlm.nih.gov/36250082/. DOI: 10.3389/fmed.2022.999804.
|
9. |
Kianersi F, Kianersi H, Pourazizi M, et al. Fuchs' uveitis syndrome: a 20-year experience in 466 patients[J/OL]. Sci Rep, 2024, 14(1): 8621[2024-04-14]. https://pubmed.ncbi.nlm.nih.gov/38616214/. DOI: 10.1038/s41598-024-59393-w.
|
10. |
Rosenbaum JT, Pasadhika S. Ocular sarcoidosis[J]. Clin Chest Med, 2024, 45(1): 59-70. DOI: 10.1016/j.ccm.2023.08.003.
|
11. |
Tsui JK, Poon SHL, Fung NSK. Ocular manifestations and diagnosis of tuberculosis involving the uvea: a case series[J]. Trop Dis Travel Med Vaccines, 2023, 9(1): 20. DOI: 10.1186/s40794-023-00205-w.
|
12. |
Zarei M, Darabeigi S, Mehrpour M, et al. Fuchs' uveitis in Iranian patients: a review of 89 eyes[J]. Ocul Immunol Inflamm, 2019, 27(7): 1077-1085. DOI: 10.1080/09273948.2018.1500612.
|
13. |
Nalçacıoğlu P, Çakar Özdal P, Şimşek M. Clinical characteristics of Fuchs' uveitis syndrome[J]. Turk J Ophthalmol, 2016, 46(2): 52-57. DOI: 10.4274/tjo.99897.
|